Tue Jan 14 , 2025
Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, Keytruda, and he described the future of its other ventures. “Keytruda has truly been transformational in the treatment of cancer,” he said. “But, importantly, we are now in a situation […]
